Ester Baiget, CEO of Novonesis, shared her perspective on the impact of tariffs on investment strategies in a recent interview. While she stated that Novonesis, a biotech firm based in Denmark, remains resilient against U.S. tariffs, Baiget voiced concerns about the uncertainty these levies create within the investment landscape. She highlighted that such unpredictability pauses critical investment decisions, which could have long-term effects on business growth and development. This discussion accentuates the need to closely monitor the implications of tariffs on various sectors, especially for companies engaged in international trade.